x
Breaking News
More () »

MercyOne offering new treatment for high-risk COVID patients

The FDA authorized an emergency use authorization for Eli Lilly's monoclonal antibody treatment, Bamlanivimab, on Nov. 9.

Before You Leave, Check This Out